Roche Holding | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 306.72B 7.3B 2025-04
Alcon AG CHF 37.16B 1.27B 2025-04
Almirall EUR 2B 233.12M 2025-04
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 157.7B 4.61B 2025-04
Bayer EUR 20.62B 1.09B 2025-04
Biogen USD 17.08B 5.2B 2025-04
Bristol-Myers Squibb USD 100.66B 14.06B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Fresenius EUR 21.93B 3.04B 2025-04
Fresenius Medical Care EUR 12.25B 734.92M 2025-04
Galapagos EUR 1.44B 316.19M 2025-04
Genmab DKK 82.03B 16.76B 2025-04
Gilead Sciences USD 131.99B 16.9B 2025-04
GlaxoSmithKline GBP 55.34B 469.7M 2025-04
GRIFOLS EUR 3.41B 3.07B 2025-04
Hikma Pharmaceutical GBP 4.18B 241.88M 2025-04
Lonza CHF 38.65B 136.39M 2025-04
Merck EUR 50.52B 4.57B 2025-04
Merck USD 196.74B 54.91B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Orion EUR 6.03B 927.26M 2024-12
Pfizer USD 126.33B 24.01B 2025-04
Philips EUR 23.05B 4.37B 2024-12
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sanofi EUR 118.41B 10.58B 2024-12



Roche Holding Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.